7 December 2021 in Bioengineered
As the second most common cancer among women, cervical cancer is a huge threat to their health all over the world. Integral membrane protein 2A (ITM2A), a member of the Type II Integral Membrane protein (ITM2) family, has been reported to act as a tumor suppressor in breast cancer and ovarian cancer. Moreover, the low expression of ITM2A was associated with cervical adenocarcinoma. However, the function of ITM2A in drug resistance in cervical cancer remains unclear. Here, we used bioinformatics methods to screen differentially expressed genes (DEGs) closely related to chemotherapeutic relapse cervical carcinoma. ITM2A is downregulated in cervical tumor tissues and is associated with poor survival. Furthermore, ITM2A is also downregulated in cervical cancer cells with cisplatin resistance. Overexpression of ITM2A increases the cisplatin sensitivity of cervical cancer cells. Mechanically, ITM2A upregulation mediates the sensitivity of cervical cancer cell through Notch signaling pathway. Our study suggests that ITM2A may serve as a target in mediating cisplatin-resistant cervical cancer.
1 May 2025 in International Journal of Women's Health
Purpose: The aim of this study is to develop a predictive model for the therapeutic efficacy of high-intensity focused ultrasound (HIFU) ablation in the treatment of adenomyosis, utilizing dual-sequence MRI radiomics. Methods: A retrospective analysis was conducted on 114 patients diagnosed with adenomyosis who underwent ultrasound-guided HIFU ablation under conscious sedation between July 2021 and July 2023. Patients were randomly allocated into a training set and a test set at a ratio of 7:3. The study aimed to evaluate the distribution of clinical characteristics among patients experiencing effective versus ineffective ablation at two distinct classification thresholds (0.7 and 0.5). Multiple models were developed to explore the combination of effective radiomic features derived from dual-sequence MRI and clinical data. Radiomic features were extracted from the MRI images of adenomyosis lesions in the training set. This process included feature extraction, selection, model construction, and evaluation. Logistic regression was used to construct the predictive model, and its performance was assessed on the test set using the receiver operating characteristic (ROC) curve. The Delong test, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were used to compare the predictive accuracy of the models. Results: The predictive model showed better alignment with actual ablation outcomes, particularly for predicting ablation success rates exceeding 50%. The combination of radiomic features from the two MRI sequences achieved an AUC of 0.84 in the test set. Decision curve analysis demonstrated that the combined model provided greater net benefit than the single-sequence radiomics model across a broader range of risk thresholds. For the prediction of 70% efficacy, the combined model achieved an AUC of 0.804 in the test set, slightly lower the 50% efficacy prediction task. Conclusion: The model, based on dual-sequence MRI radiomics, emerges as a promising tool for predicting the efficacy of HIFU ablation, potentially aiding clinicians in anticipating the outcomes of HIFU ablation procedures.
3 March 2025 in Frontiers in Endocrinology
Background: A major problem that affects women of reproductive age globally is sterility. A new statistic called Relative Fat Mass (RFM) provides an accurate representation of the percentage of total body fat in people. This study aims to investigate the relationship between RFM and sterility in fertility-age American women.Methods: This study employed a cross-sectional design using data collected from NHANES between 2013 and 2018. The association between RFM and sterility was investigated using logistic regression analysis, controlling for a number of variables. The results were more resilient when RFM was transformed into a four-category variable in order to further examine the patterns of the association between different RFM levels and sterility. The dose-response association between RFM and sterility was illustrated using restricted cubic spline (RCS) analysis. Sensitivity and subgroup analyses were also conducted to assess the robustness and consistency of the results.Results: This study included 3,197 women aged 18–45, consisting of 2,854 non-sterile participants and 343 sterile participants. First, in the fully adjusted model, RFM and the prevalence of sterility had a positive correlation (OR = 1.05, 95% CI = 1.01–1.09). When converting RFM from a continuous to a categorical variable, the prevalence of sterility was significantly greater in the highest quartile than in the lowest quartile (OR = 2.59, 95% CI = 1.40–4.82). Furthermore, RFM and sterility prevalence were found to be positively linearly correlated by RCS analysis, with sterility rates sharply increasing as RFM levels rose. The positive correlation between RFM and the frequency of sterility was shown to be constant throughout various populations, according to subgroup analysis across stratified parameters. Finally, sensitivity analysis further confirmed the reliability and consistency of the study’s findings.Conclusion: A representative sample of American women of reproductive age showed a positively correlation between RFM and the prevalence of sterility. RFM may help identify women at risk for sterility, and waist circumference management could potentially help lower the risk of sterility.